FIG. 6.

Decrease in IL-17 levels at uterine implantation sites. (A) IL-17 levels were obviously reduced at implantation sites based on immunohistochemistry. Scale bars=200 and 50 μm. At least 3 independent experiments were repeated for each time point. The data at each point were derived from 3 separate samples from pregnant mice. A total of 18 samples from pregnant mice were assessed. (B) IL-17 levels were significantly reduced at implantation sites based on Western blotting. GAPDH was used as a loading control. The bars represent the SD of the mean of the relative value in gray (IL-17/GAPDH). A paired t-test was used to assess the significance of differences. *P<0.05, IFN-γ treatment group versus the corresponding saline control group. At least 3 independent experiments were repeated for each time point.